The compounded route circumvents the formulary problem entirely because the medications arent on formularies
A higher dose of semaglutide increases your risk of side effects The STEP UP study was a phase 3 clinical trial to see whether the 7.2-milligram dose of semaglutide was both safe and effective
Historically, results of this magnitude were almost exclusively seen following bariatric surgery
Lower average medication levels mean weaker appetite controlpotentially leading to weight regain
The oral maximum is 25 mg daily (Wegovy 25 mg pill, approved December 2025) or 14 mg daily (Rybelsus)
Current treatments, including laparoscopic excision, hormonal therapy and non-steroidal anti-inflammatory drugs, provide relief but are not curative 1,5,7,12